GLP-1 drugs like Ozempic could cut risk of major heart complications after heart attack, study finds
Weight-loss (GLP-1 mimicking) drugs may help prevent further tissue damage following a heart attack, significantly reducing the risk of further life-threatening complications that affect up to half of all patients, according to a new study led by the University of Bristol and University College London (UCL).







.png)

